Heart Failure

Heart failure occurs when the heart cannot pump as much blood as the body requires. This ineffective pumping can lead to enlargement of the heart as the myocardium works harder pump the same amount of blood. Heart failure may be caused by defects in the myocardium, such as an a heart attack infarct, or due to structural issues such as severe heart valve regurgitation. Heart failure can be divided into HF with preserved ejection fraction (HFpEF), and HF with reduced ejection fraction (HFrEF). The disease is further divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or hemodynamic support from a left ventricular assist device (LVAD).

RSS icon

TPV valves, CTO PCI and more: SCAI 2022 updates for interventional cardiologists

The first two days of SCAI 2022 were jam-packed with innovative technologies and late-breaking research.

David Bennett

How did the pig heart transplant patient die? A preventable infection may be to blame

The genetically modified pig heart appears to have been infected with a porcine virus, according to the surgeon who performed the initial transplant. 

transcatheter aortic valve replacement (TAVR) procedure guided by CT fusion imaging on a patient with heart failure and a blood clot

Cardiologists and surgeons perform first TAVR using CT imaging guidance on HF patient with blood clot

“We believe this case is potentially groundbreaking," one interventional cardiologist said. 

interventional cardiology heart failure cleveland clinic

4 promising heart failure therapies interventional cardiologists should keep an eye on

The devices, currently being investigated by teams of heart specialists, could make a big impact in the years ahead. 

mavacamten

FDA approves mavacamten for obstructive hypertrophic cardiomyopathy

The FDA’s approval was based on data from the EXPLORER-HCM trial, which showed that mavacamten was superior to a placebo for treating obstructive HCM and associated with no significant long-term, treatment-related adverse events.

Thumbnail

Heart failure hospitalizations among young adults are getting more common and more expensive

Researchers examined data from more than 750,000 heart failure hospitalizations, sharing their findings in JACC: Heart Failure. 

Machinist Patrick Leibich of Penn State College of Medicine’s division of Applied Biomedical Engineering works to create artificial heart parts. Image courtesy of Penn State.

Penn State researchers receive more than $3 million to develop new-look artificial heart

The group will be working to develop a wireless artificial heart that can last at least 10 years. 

fda recall Accupril pfizer

FDA announces another recall of common hypertension medication due to potential cancer risk

The new recall includes five lots of medications distributed from December 2019 to April 2022. Similar products were also recalled back in March for the same reason.

Displaying 241 - 248 of 645
Design by Adaptive Theme